Melane Sampson, Author at BioTuesdays

Developments

Medigene secures patents advancing TCR-guided therapies

Medigene AG (FSE:MDG1) has announced that patents have been granted for its proprietary JOVI and iM-TCR technologies, enhancing the company’s End-to-End (E2E) platform of TCR-guided therapies for the treatment of cancer...

August 29, 2024

Developments

Gain reports positive topline results from Phase 1 trial of therapy for Parkinson’s

Gain Therapeutics (NASDAQ:GANX) has announced positive results from its Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GT-02287, a novel GCase-targeting small molecule therapy for Parkinson’s...

August 29, 2024

Executive Moves

MOBILion appoints Rohit Khanna to BOD

Closely-held MOBILion Systems has announced the appointment of seasoned life sciences executive, Rohit Khanna, Ph.D., to its board, effective immediately. Dr. Khanna co-founded software engineering firm Dynamic...

August 28, 2024

Developments

LIXTE and NKI dose first patient with LB100 in colorectal cancer study supported by Roche

LIXTE Biotechnology (NASDAQ:LIXT) has announced that, in collaboration with the Netherlands Cancer Institute (NKI), the first patient has been dosed in a new clinical trial of LUXTE’s lead compound, LB-100, for the...

August 26, 2024

Developments

Emergent donates 50,000 smallpox vaccine doses in response to WHO’s mpox declaration

Emergent BioSolutions (NYSE:EBS) announced its pledge to donate 50,000 doses of its ACAM2000 smallpox vaccine through Direct Relief in response to WHO’s declaration that the upsurge of mpox in the Democratic Republic of...

August 20, 2024

Developments

Tonix enrolls first patient in Phase 2 study of TX1300 for acute cocaine intoxication

Tonix Pharmaceuticals (NASDAQ:TNXP) announced the first patient dosing in its Phase 2 trial of the recombinant enzyme TNX-1300 for treating life-threatening cocaine intoxication in patients presenting to the emergency...

August 20, 2024

Feature

Entera Bio’s EB613 Oral PTH(1-34) Tablets Poised to Revolutionize Osteoporosis Care for 200 Million Post-Menopausal Women Globally

Entera Bio (NASDAQ:ENTX) is leveraging a disruptive technology platform called N-Tab to develop first-in-class, once-daily oral tablets of peptides and small therapeutic protein replacement therapies. The company...

August 20, 2024

Executive Moves

ANEW Medical appoints Jeffrey LeBlanc as CFO

ANEW Medical (NASDAQ:WENA) announced the appointment of Jeffrey LeBlanc as its new CFO, succeeding interim CFO, Edward Cong Wang, the former CFO of Redwoods Acquisition, which ANEW merged with. ANEW’s portfolio includes...

August 19, 2024

Developments

First participant dosed in Monte Rosa’s Phase 1 study of MRT-6160 for autoimmune disease

Monte Rosa Therapeutics (NASDAQ:GLUE) announced that the first participant has been dosed in its Phase 1 healthy volunteer study evaluating MRT-6160, a VAV1-directed MGB being developed for systemic and neurological...

August 19, 2024

Developments

Optimi Health announces export of first MDMA capsules for PTSD to Australia

Optimi Health (CSE:OPTI; OTCQX:OPTHF; FSE:8BN) reports completion of its inaugural export of GMP-validated, 3,4-methylenedioxymethamphetamine (MDMA) capsules to Australia for the treatment of patients with post...

August 16, 2024

Author - Melane Sampson

Medigene secures patents advancing TCR-guided therapies

Gain reports positive topline results from Phase 1 trial of therapy for Parkinson’s

MOBILion appoints Rohit Khanna to BOD

LIXTE and NKI dose first patient with LB100 in colorectal cancer study supported by Roche

Emergent donates 50,000 smallpox vaccine doses in response to WHO’s mpox declaration

Tonix enrolls first patient in Phase 2 study of TX1300 for acute cocaine intoxication

Entera Bio’s EB613 Oral PTH(1-34) Tablets Poised to Revolutionize Osteoporosis Care for 200 Million Post-Menopausal Women Globally

ANEW Medical appoints Jeffrey LeBlanc as CFO

First participant dosed in Monte Rosa’s Phase 1 study of MRT-6160 for autoimmune disease

Optimi Health announces export of first MDMA capsules for PTSD to Australia

General

More